Regulatory pathways for microbial ferment serums differ significantly across the US, EU, China, and Japan, and choosing your primary launch market early in development will shape your formula, testing, and timeline. There is no single global 'cosmetic standard'—each region has its own definition of what a cosmetic is, what safety data is required, and what claims are permissible.
In the United States, a microbial ferment serum is regulated as a cosmetic under the FDA's Federal Food, Drug, and Cosmetic Act (FFDCA) unless it makes a drug claim (e.g., 'reduces acne,' 'reverses wrinkles,' 'heals barrier damage'). A cosmetic ferment serum can claim 'hydrating,' 'smoothing,' 'firming to appearance,' or 'soothing'—these are cosmetic claims that describe physical effect without treating or curing disease. The FDA does not require pre-market approval for cosmetics; instead, the product must be truthful, not misbranded, and safe. This means your ferment serum must be formulated to prevent microbial contamination (preservative efficacy must pass a challenge test), all ingredients must be either on the FDA's GRAS (Generally Recognized As Safe) list or have substantiation for safety at your use level, and the formula must have stability data demonstrating that it maintains safety and efficacy over its stated shelf-life (typically 12–24 months for a serum).
For US-only launch, your testing requirements are minimal compared to other regions: You need a Certificate of Analysis for all ingredients (especially the ferment) documenting microbial limits, a preservative efficacy challenge test ($400–1,200), a microbial limit test on the finished product ($300–800), and a basic stability protocol (4 weeks accelerated at 45°C + 12 weeks real-time at 25°C/60% RH) costing $1,500–3,000. Total compliance investment: $2,500–5,000 for a 250-unit batch. Your lab will also prepare an FDA Cosmetic Product Safety Summary (which is not submitted pre-market but is required for FDA inspection), and the product must be labeled with an ingredient list (INCI names), net quantity, manufacturer name and address, warnings (if any), and instructions for use. Fermented ingredients with established INCI names (e.g., 'Lactobacillus Ferment Filtrate') can be declared as-is. Custom ferments without a published INCI name must be declared descriptively or go through INCI petition (2–4 weeks additional).
The European Union has stricter pre-market requirements. Your microbial ferment serum is defined as a cosmetic under Regulation (EC) 1223/2009 (the Cosmetics Regulation), and all finished cosmetics must be notified to the CPNP (Cosmetic Products Notification Portal) before they are placed on the EU market. This requires a Safety Assessment, typically conducted by a cosmetic toxicologist, that evaluates your formula's safety profile based on ingredient toxicology, stability, preservative efficacy, contaminant limits, and any hazard warnings. The assessment must be compliant with the SCCS (Scientific Committee on Consumer Safety) guidelines. For a fermented ingredient, the assessment must verify that the organism has been inactivated or is absent in the final product (live bacteria in a cosmetic are not permitted because they pose undefined risks), that there is no cross-reactivity or allergenicity from residual bacterial proteins or cell-wall fragments, and that preservative efficacy is robust across shelf-life.
EU testing requirements for a microbial serum are more extensive than US requirements: Preservative efficacy challenge test (same as US, $400–1,200), microbial limit test ($300–800), heavy metals by ICP-MS ($200–400), stability protocol with 12 weeks real-time at 25°C/60% RH minimum ($2,000–3,500), allergen screening if applicable ($150–300), and a formal Safety Assessment by a qualified toxicologist ($800–2,000). Total: $4,500–8,500 for a 250-unit batch. Additionally, your Safety Assessment dossier must be held by a Responsible Person (RP)—this can be the brand owner, the lab, or a regulatory consultant in the EU. If the lab is outside the EU, you must appoint a regulatory representative within the EU to interface with authorities and hold the dossier. The entire submission to CPNP includes your Safety Assessment, SDS (Safety Data Sheet) for the product, and declaration of NRCB (Non-Restrict Colorants and Restrictive Substances). Notification is typically complete within 1–2 weeks of submission, but you must wait at least one day from submission before launch (it's not a pre-market approval, but a regulatory record).
China's NMPA (National Medical Products Administration, formerly CFDA) distinguishes between imported cosmetics (which must be registered pre-market) and domestic cosmetics (which are registered but with less stringent requirements). If you're exporting a microbial ferment serum to China, it's classified as an imported cosmetic and must go through NMPA registration before sale. This requires a full Safety Assessment, stability data (12 months real-time minimum), efficacy substantiation for any claims, and microbial and chemical testing. The NMPA also requires that live organisms are not present; a fermented serum must have been inactivated and must include a stability claim for shelf-life. Processing time: 90–180 days for registration. Testing cost is higher in China ($6,000–12,000 for a full dossier) because NMPA-accredited labs are limited and have strict protocols. China also prohibits certain ingredients (e.g., some preservatives used in the US and EU are restricted in China), so you may need to reformulate if China is a target market. Additionally, China requires that imported cosmetics with any therapeutic claim (even 'soothing' or 'anti-inflammatory') go through a more rigorous drug-like evaluation. For indie founders, it's often better to launch in the US, EU, or Japan first and defer China to a second phase once sales volume justifies the registration cost.
Japan's regulatory framework is less burdensome than China's but stricter than the US. The METI (Ministry of Economy, Trade, and Industry) and PMDA (Pharmaceuticals and Medical Devices Agency) regulate cosmetics under the Pharmaceutical Affairs Law (PAL). A microbial ferment serum is classified as a cosmetic if it makes only cosmetic claims (e.g., 'hydration,' 'smoothing'); if it claims any therapeutic effect (e.g., 'reduces inflammation,' 'treats acne'), it's reclassified as an over-the-counter medicine (quasi-drug) with much stricter requirements. For a cosmetic serum, your requirements are: a product notification to METI (no pre-market approval, but a regulatory record), a Safety Assessment, stability data (12 months minimum), and microbial testing. Japan requires that all ingredients are either pre-approved (on an established cosmetic ingredient list) or undergo safety substantiation. Many fermented ingredients are now on Japan's approved list, making registration easier. Testing cost for Japan-only launch: $3,000–6,000. Notification processing time: 1–2 weeks. Japan also accepts 'hyaluronic acid produced by fermentation' or similar descriptive claims, which gives you marketing flexibility for fermented serums.
Key differences in claims across markets: The US allows broad cosmetic claims ('firming,' 'smoothing,' 'plumping') without substantiation data. The EU permits only claims supported by evidence and discourages 'anti-aging' terminology (the SCCS prefers 'age-defying' or 'appearance of firmer skin'). China prohibits many claims outright and requires proof for therapeutic-adjacent claims. Japan is liberal with cosmetic claims but strict on disease-prevention claims (which flip the product into drug category). A serum formulated for the US market with claims like 'visibly reduces fine lines' may need to soften claims for EU launch to 'improves appearance of fine lines' or eliminate them entirely for China.
Multi-market strategy: If you're planning a global launch, it's most efficient to develop your formula to the strictest market first (typically EU or China), then scale to the less stringent markets. EU compliance automatically covers US requirements in most respects (EU testing is more thorough). However, if your primary market is the US with later expansion, start with a US formula and stability package, then layer on EU or China testing as sales grow. Attempting simultaneous global launch for a low-MOQ product is expensive and slow; phased expansion is more practical.
Microbial-specific regulatory notes: All markets require that your fermented ingredient is either inactivated (confirmed by microbial viability testing showing <1 CFU/mL) or present as a cell-free filtrate (no intact cells). A serum claiming 'live probiotics' or 'live cultures' is not permissible in any major cosmetic market because the microbes cannot be controlled, validated for safety, or guaranteed viable across shelf-life in a cosmetic matrix. Some labs market 'postbiotics' or 'ferment metabolites' as an alternative, which is the metabolic byproducts of inactivated fermentation—this is permissible everywhere and avoids the liability of live organisms.
The most common regulatory mistake indie founders make is launching in the US without realizing they later can't export to EU or Japan without additional testing. Testing that's compliant with US standards (e.g., a 4-week accelerated stability) is often insufficient for EU (which requires 12 weeks real-time minimum). Building compliance for EU or Japan upfront costs more initially but saves rework if you plan global expansion. Working with a regulatory consultant on AJ Cosmo Labs or through your chosen manufacturer ensures your formula is mapped to your intended markets from day one, avoiding costly reformulation mid-launch.
Ingredients in this answer: Hyaluronic Acid
Read the full guide on Private Label Microbial Ferment Serum Manufacturer Low MOQ →